Saved in:
Bibliographic Details
Main Author: Óscar Alzate
Format: Artículo científico
Language:en
Published: Universidad Nacional de Colombia 2006
Subjects:
Online Access:https://www.redalyc.org/articulo.oa?id=77680105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866586822552846336
author Óscar Alzate
author_facet Óscar Alzate
contents TGF-b and a specific TGF-b inhibitor regulate pericentrin B and MYH9 in glioma cell lines Óscar Alzate Cristina Osorio Michael H. Herbstreith Mark Hjelmeland Robert Buechler Dong Ning He Shideng Bao Jeremy N. Rich Biología TGF DIGE glioma proteomics pericentrin B Malignant gliomas are heterogeneous, highly invasive vascular tumours. The multifunctional cytokine, transforminggrowth factor-beta (TGF-b), is expressed by grade III/IV gliomas and promotes tumour angiogenesis, invasion andimmune escape. It has been shown previously that a small TGF-b receptor type I (TGF-b-RI) molecule inhibitor (SB-431542) blocks TGF-b-mediated signal transduction, induction of angiogenic factor expression and cellular motility.As glioma cell lines display differential sensitivity to TGF-b, it was expected that they would also be differentiallyimpacted by disruption of TGF-b signalling. Differential in gel expression (DIGE) analysis and mass spectrometrywas used in this work for determining protein regulation effects of both TGF-b and SB-431542 on human glioma celllines. It was found that pericentrin B and non muscle myosin were differentially expressed in fragments which likelyresulted from protease activation by the tumour growth mechanism. These results suggest that both pericentrin B andnon-muscle myosin might be potential glioma biomarkers. 2006 artículo científico 0123-3475 https://www.redalyc.org/articulo.oa?id=77680105 en http://www.redalyc.org/revista.oa?id=776 Revista Colombiana de Biotecnología application/pdf Universidad Nacional de Colombia Revista Colombiana de Biotecnología (Colombia) Num.1 Vol.VIII
format Artículo científico
id redalyc_77680105
language en
publishDate 2006
publisher Universidad Nacional de Colombia
spellingShingle TGF-b and a specific TGF-b inhibitor regulate pericentrin B and MYH9 in glioma cell lines
Óscar Alzate
Biología
TGF
DIGE
glioma
proteomics
pericentrin B
TGF-b and a specific TGF-b inhibitor regulate pericentrin B and MYH9 in glioma cell lines Óscar Alzate Cristina Osorio Michael H. Herbstreith Mark Hjelmeland Robert Buechler Dong Ning He Shideng Bao Jeremy N. Rich Biología TGF DIGE glioma proteomics pericentrin B Malignant gliomas are heterogeneous, highly invasive vascular tumours. The multifunctional cytokine, transforminggrowth factor-beta (TGF-b), is expressed by grade III/IV gliomas and promotes tumour angiogenesis, invasion andimmune escape. It has been shown previously that a small TGF-b receptor type I (TGF-b-RI) molecule inhibitor (SB-431542) blocks TGF-b-mediated signal transduction, induction of angiogenic factor expression and cellular motility.As glioma cell lines display differential sensitivity to TGF-b, it was expected that they would also be differentiallyimpacted by disruption of TGF-b signalling. Differential in gel expression (DIGE) analysis and mass spectrometrywas used in this work for determining protein regulation effects of both TGF-b and SB-431542 on human glioma celllines. It was found that pericentrin B and non muscle myosin were differentially expressed in fragments which likelyresulted from protease activation by the tumour growth mechanism. These results suggest that both pericentrin B andnon-muscle myosin might be potential glioma biomarkers. 2006 artículo científico 0123-3475 https://www.redalyc.org/articulo.oa?id=77680105 en http://www.redalyc.org/revista.oa?id=776 Revista Colombiana de Biotecnología application/pdf Universidad Nacional de Colombia Revista Colombiana de Biotecnología (Colombia) Num.1 Vol.VIII
title TGF-b and a specific TGF-b inhibitor regulate pericentrin B and MYH9 in glioma cell lines
topic Biología
TGF
DIGE
glioma
proteomics
pericentrin B
url https://www.redalyc.org/articulo.oa?id=77680105